共 50 条
- [1] Six-Year Retention Rates with Abatacept vs TNF inhibitors in the Treatment of Rheumatoid Arthritis: Experience from the Real-world Rhumadata Clinical Database and RegistryJOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1211 - 1212Choquette, DenisBessette, LouisHaraoui, BoulosRaynauld, Jean-PierreSauvageau, DianeTurcotte, AngeleVilleneuve, EdithMassicotte, FredericBrown, JacquesCoupal, Louis
- [2] Retention Rates of TNF Inhibitors and Abatacept Used as a First Biologic DMARD in the Treatment of Rheumatoid Arthritis: 8 Years of Experience from the Rhumadata® RegistryJOURNAL OF RHEUMATOLOGY, 2018, 45 (07) : 1053 - 1053Choquette, DenisBessette, LouisAlemao, EvoHaraoui, BoulosMassicotte, FredericMtibaa, MondherMuratti, EleonoraPelletier, Jean-PierrePostema, RoelienRaynauld, Jean-PierreRemillard, Marie-AnaisSauvageau, DianeTurcotte, AngeleVilleneuve, EdithCoupal, Louis
- [3] RETENTION RATES OF TNF INHIBITORS AND ABATACEPT USED AS A FIRST BIOLOGIC DMARD IN THE TREATMENT OF RHEUMATOID ARTHRITIS: 8 YEARS OF EXPERIENCE FROM THE RHUMADATA® REGISTRYANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 571 - 572Choquette, D.Bessette, L.Alemao, E.Haraoui, B.Massicotte, F.Mtibaa, M.Muratti, E.Pelletier, J-P.Postema, R.Raynauld, J-P.Remillard, M-A.Sauvageau, D.Turcotte, A.Villeneuve, E.Coupal, L.
- [4] Persistence rates of abatacept and TNF inhibitors used as first or second biologic DMARDs in the treatment of rheumatoid arthritis: 9 years of experience from the Rhumadata® clinical database and registryArthritis Research & Therapy, 21Denis ChoquetteLouis BessetteEvo AlemaoBoulos HaraouiRoelien PostemaJean-Pierre RaynauldLouis Coupal
- [5] Persistence rates of abatacept and TNF inhibitors used as first or second biologic DMARDs in the treatment of rheumatoid arthritis: 9years of experience from the Rhumadata® clinical database and registryARTHRITIS RESEARCH & THERAPY, 2019, 21 (1)Choquette, DenisBessette, LouisAlemao, EvoHaraoui, BoulosPostema, RoelienRaynauld, Jean-PierreCoupal, Louis
- [6] Abatacept Shows Better Sustainability than TNF Inhibitors when Used Following Initial Biologic DMARD Failure in the Treatment of Rheumatoid Arthritis: 8 Years of Real-World Observations from the Rhumadata® Clinical Database and RegistryJOURNAL OF RHEUMATOLOGY, 2018, 45 (07) : 1053 - 1053Choquette, DenisBessette, LouisAlemao, EvoHaraoui, BoulosMassicotte, FredericMtibaa, MondherMuratti, EleonoraPelletier, Jean-PierrePostema, RoelienRaynauld, Jean-PierreRemillard, Marie-AnaisSauvageau, DianeTurcotte, AngeleVilleneuve, EdithCoupal, Louis
- [7] ABATACEPT SHOWS BETTER SUSTAINABILITY THAN TNF INHIBITORS WHEN USED FOLLOWING INITIAL BIOLOGIC DMARD FAILURE IN THE TREATMENT OF RHEUMATOID ARTHRITIS: 8 YEARS OF REAL-WORLD OBSERVATIONS FROM THE RHUMADATA® CLINICAL DATABASE AND REGISTRYANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1188 - 1188Choquette, D.Bessette, L.Alemao, E.Haraoui, B.Massicotte, F.Mtibaa, M.Muratti, E.Pelletier, J-P.Postema, R.Raynauld, J-P.Remillard, M-A.Sauvageau, D.Turcotte, A.Villeneuve, E.Coupal, L.
- [8] Retention on Adalimumab, Etanercept, Golimumab and Infliximab in Two Eras - Experience of Patients with Rheumatoid Arthritis from a Real-World Database RHUMADATA®ARTHRITIS & RHEUMATOLOGY, 2017, 69Choquette, DenisBessette, LouisCoupal, LouisGarces, Kirsten
- [9] Disease and Treatment Characteristics That Might Influence Long-Term Retention with Biologics in the Real-World Clinical Setting: Experience from the Rhumadata Clinical Database and RegistryARTHRITIS & RHEUMATOLOGY, 2015, 67Choquette, DenisBessette, LouisHaraoui, BoulosRaynauld, Jean-PierreSauvageau, DianeTurcotte, AngeleVilleneuve, EdithCoupal, Louis
- [10] Disease and Treatment Characteristics that Might Influence Long-term Retention with Biologics in the Real-world Clinical Setting: Experience from the Rhumadata Clinical Database and RegistryJOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1212 - 1212Choquette, DenisBessette, LouisHaraoui, BoulosRaynauld, Jean-PierreSauvageau, DianeTurcotte, AngeleVilleneuve, EdithMassicotte, FredericBrown, JacquesCoupal, Louis